New Navinci in situ proximity ligation kits for Leica BOND RX/RXm with fluorescent readout
Building on the success of our initial Naveni® in situ kits, we are now introducing two new products with fluorescence readout: NaveniFlex™ BOND RX Atto647N/Red and Naveni® PD1/PD-L1 BOND RX Atto647N/Red. These products expand the capabilities of in situ proximity ligation assays with automated workflows on the Leica BOND RX/RXm Fully Automated Research Stainer to achieve increased throughput and consistent high-quality results.
Our portfolio now includes both chromogenic and fluorescence readouts, providing researchers with greater flexibility for in situ detection. Based on the innovative Naveni® in situ proximity ligation technology, these kits are designed for seamless integration into your automated research processes, ensuring reliability, sensitivity, and ease of use.
NaveniFlex BOND RX Atto647N/Red introduces a new assay, seamlessly integrating fluorescent readout automation on the Leica Biosystems BOND RX platform. Based on Navinci’s advanced Naveni® in situ proximity ligation technology, this in situ kit provides flexibility tailored to customers’ primary antibodies and targets.
Naveni® PD1/PD-L1 BOND RX Atto647N/Red addresses a critical need in immuno-oncology by enabling specific detection of PD1/PD-L1 interactions in situ. This capability improves reproducibility and throughput, allowing researchers to study this key immune checkpoint in larger cohorts.
Find out more at SITC 2024
To find out more about the new kits by visiting Navinci at booth #834 or Leica Biosystems at booth #706 at this year’s Society for Immunotherapy of Cancer (SITC) Annual Meeting in Houston, Texas, November 7-10.
Read more
For additional information about Navinci, Leica Biosystems, and the newly launched solutions, please visit leicabiosystems.com or navinci.se/technology/naveni-bond
For Research Use Only. Not for use in diagnostic procedures.
